News + Filings Transactions Holdings
All 13F 13D/G Other
|
Barlow David S
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/28/2011 |
4
| Barlow David S (10% Owner) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc.
Txns:
| Sold 33,000 shares
@ $0.17, valued at
$5.6k
Sold 5,000 shares
@ $0.18, valued at
$900 Sold 17,000 shares
@ $0.15, valued at
$2.6k
Sold 6,000 shares
@ $0.141, valued at
$846 Sold 6,000 shares
@ $0.16, valued at
$960 Sold 9,000 shares
@ $0.171, valued at
$1.5k
Sold 21,000 shares
@ $0.175, valued at
$3.7k
|
|
12/20/2010 |
4
| Barlow David S (10% Owner) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc.
Txns:
| Sold 24,000 shares
@ $0.21, valued at
$5k
Sold 19,000 shares
@ $0.22, valued at
$4.2k
Sold 2,000 shares
@ $0.23, valued at
$460 Sold 31,000 shares
@ $0.19, valued at
$5.9k
Sold 2,000 shares
@ $0.21, valued at
$420 Sold 122,000 shares
@ $0.2, valued at
$24.4k
|
|
08/30/2010 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
08/13/2010 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
08/12/2010 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
01/21/2010 |
4
| Barlow David S (10% Owner) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc.
Txns:
| Sold 200 shares
@ $2.06, valued at
$412 Sold 800 shares
@ $2.07, valued at
$1.7k
Sold 500 shares
@ $2.09, valued at
$1k
Sold 500 shares
@ $2.08, valued at
$1k
Sold 1,000 shares
@ $2.08, valued at
$2.1k
Sold 500 shares
@ $2.04, valued at
$1k
Sold 500 shares
@ $2.05, valued at
$1k
Sold 500 shares
@ $1.95, valued at
$975 Sold 500 shares
@ $1.99, valued at
$995 Sold 500 shares
@ $1.96, valued at
$980 Sold 300 shares
@ $2.05, valued at
$615 |
|
01/06/2010 |
4/A
| Barlow David S (10% Owner) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc.
Txns:
| Sold 2,000 shares
@ $2.31, valued at
$4.6k
Sold 2,000 shares
@ $2.32, valued at
$4.6k
Sold 1,000 shares
@ $2.33, valued at
$2.3k
Sold 900 shares
@ $2.37, valued at
$2.1k
Sold 2,000 shares
@ $2.4, valued at
$4.8k
Sold 2,000 shares
@ $2.41, valued at
$4.8k
Sold 1,000 shares
@ $2.41, valued at
$2.4k
Sold 1,000 shares
@ $2.42, valued at
$2.4k
Sold 100 shares
@ $2.36, valued at
$236 Sold 1,000 shares
@ $2.34, valued at
$2.3k
Sold 500 shares
@ $2.34, valued at
$1.2k
|
|
01/06/2010 |
4/A
| Barlow David S (10% Owner) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc.
Txns:
| Sold 500 shares
@ $2.27, valued at
$1.1k
Sold 500 shares
@ $2.26, valued at
$1.1k
Sold 500 shares
@ $2.25, valued at
$1.1k
Sold 500 shares
@ $2.28, valued at
$1.1k
Sold 500 shares
@ $2.24, valued at
$1.1k
Sold 300 shares
@ $2.33, valued at
$699 Sold 500 shares
@ $2.32, valued at
$1.2k
Sold 500 shares
@ $2.33, valued at
$1.2k
Sold 200 shares
@ $2.32, valued at
$464 Sold 500 shares
@ $2.37, valued at
$1.2k
Sold 500 shares
@ $2.34, valued at
$1.2k
|
|
12/28/2009 |
4
| Barlow David S (10% Owner) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc.
Txns:
| Sold 2,000 shares
@ $2.31, valued at
$4.6k
Sold 2,000 shares
@ $2.32, valued at
$4.6k
Sold 1,000 shares
@ $2.33, valued at
$2.3k
Sold 900 shares
@ $2.37, valued at
$2.1k
Sold 2,000 shares
@ $2.4, valued at
$4.8k
Sold 2,000 shares
@ $2.41, valued at
$4.8k
Sold 1,000 shares
@ $2.41, valued at
$2.4k
Sold 1,000 shares
@ $2.42, valued at
$2.4k
Sold 100 shares
@ $2.36, valued at
$236 Sold 1,000 shares
@ $2.34, valued at
$2.3k
Sold 500 shares
@ $2.34, valued at
$1.2k
|
|
12/28/2009 |
4
| Barlow David S (10% Owner) has filed a Form 4 on Molecular Insight Pharmaceuticals, Inc.
Txns:
| Sold 500 shares
@ $2.25, valued at
$1.1k
Sold 500 shares
@ $2.28, valued at
$1.1k
Sold 500 shares
@ $2.24, valued at
$1.1k
Sold 300 shares
@ $2.33, valued at
$699 Sold 500 shares
@ $2.32, valued at
$1.2k
Sold 500 shares
@ $2.33, valued at
$1.2k
Sold 200 shares
@ $2.32, valued at
$464 Sold 500 shares
@ $2.37, valued at
$1.2k
Sold 500 shares
@ $2.34, valued at
$1.2k
Sold 500 shares
@ $2.35, valued at
$1.2k
Sold 300 shares
@ $2.3, valued at
$690 |
|
02/10/2009 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
12/31/2008 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/03/2008 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |
02/14/2008 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
02/12/2007 |
SC 13G
| Barlow David S has filed a Schedule 13D for MOLECULAR INSIGHT PHARMACEUTICALS, INC. |
|
|